These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21095261)

  • 21. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Flynn A; Moscucci M; Share D; Smith D; LaLonde T; Changezi H; Riba A; Gurm HS
    Arch Intern Med; 2010 Nov; 170(20):1842-9. PubMed ID: 21059978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery.
    Basran S; Frumento RJ; Cohen A; Lee S; Du Y; Nishanian E; Kaplan HS; Stafford-Smith M; Bennett-Guerrero E
    Anesth Analg; 2006 Jul; 103(1):15-20, table of contents. PubMed ID: 16790618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect on long-term survival of erythrocyte transfusion given for cardiac valve operations.
    Engoren M; Habib RH; Hadaway J; Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah A
    Ann Thorac Surg; 2009 Jul; 88(1):95-100, 100.e1-3. PubMed ID: 19559202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for red blood cell transfusion after coronary artery bypass graft surgery.
    van Straten AH; Kats S; Bekker MW; Verstappen F; ter Woorst JF; van Zundert AJ; Soliman Hamad MA
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):413-7. PubMed ID: 20231104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The need for "compassionate provider profiling": refining risk assessment for percutaneous coronary intervention.
    Peterson ED
    J Am Coll Cardiol; 2011 Feb; 57(8):912-3. PubMed ID: 21329836
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of duration of red blood cell storage on early and late mortality after coronary artery bypass grafting.
    van Straten AH; Soliman Hamad MA; van Zundert AA; Martens EJ; ter Woorst JF; de Wolf AM; Scharnhorst V
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):231-7. PubMed ID: 20621313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predictive for in-hospital mortality following percutaneous coronary intervention.
    Zouaoui W; Ouldzein H; Boudou N; Dumonteil N; Bongard V; Baixas C; Galinier M; Roncalli J; Elbaz M; Puel J; Fauvel JM; Carrié D
    Arch Cardiovasc Dis; 2008; 101(7-8):443-8. PubMed ID: 18848686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
    Jeremias A; Gruberg L; Patel J; Connors G; Brown DL
    Am J Cardiol; 2010 May; 105(9):1268-71. PubMed ID: 20403477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods.
    Luten M; Roerdinkholder-Stoelwinder B; Schaap NP; de Grip WJ; Bos HJ; Bosman GJ
    Transfusion; 2008 Jul; 48(7):1478-85. PubMed ID: 18482180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pitfalls in the current published observational literature on the effects of red blood cell storage.
    van de Watering L;
    Transfusion; 2011 Aug; 51(8):1847-54. PubMed ID: 21831185
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical consequences of the red cell storage lesion.
    Tinmouth A; Chin-Yee I
    Transfus Med Rev; 2001 Apr; 15(2):91-107. PubMed ID: 11309731
    [No Abstract]   [Full Text] [Related]  

  • 34. [Metabolic and rheologic changes in long-term hypothermia of erythrocyte concentrates over 15 weeks].
    Matthes G; Richter E; Tofoté U; Kucera W; Lerche D
    Beitr Infusionsther Transfusionsmed; 1994; 32():34-40. PubMed ID: 9480121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
    Valeri CR; Ragno G
    Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Same-day discharge is feasible and safe in the majority of elderly patients undergoing elective percutaneous coronary intervention.
    Ranchord AM; Prasad S; Seneviratne SK; Simmonds MB; Matsis P; Aitken A; Harding SA
    J Invasive Cardiol; 2010 Jul; 22(7):301-5. PubMed ID: 20603499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of elevated periprocedural blood glucose to long-term survival after percutaneous coronary intervention.
    Shah B; Liou M; Grossi E; Mass H; Lorin JD; Danoff A; Sedlis SP
    Am J Cardiol; 2005 Aug; 96(4):543-6. PubMed ID: 16098309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The controversy over the age of blood: what do the clinical trials really teach us?
    Belpulsi D; Spitalnik SL; Hod EA
    Blood Transfus; 2017 Mar; 15(2):112-115. PubMed ID: 28263167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukoreduction program for red blood cell transfusions in coronary surgery: association with reduced acute kidney injury and in-hospital mortality.
    Romano G; Mastroianni C; Bancone C; Della Corte A; Galdieri N; Nappi G; De Santo LS
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):188-95. PubMed ID: 20416894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.